Key facts
- This page summarizes Maurice Zauderer's Form 4 filing for VACCINEX, INC. (VCNX).
- 1 reported transaction and 7 derivative rows are listed below.
- Accepted by SEC: 18 Nov 2024, 16:05.
Maurice Zauderer - 14 Nov 2024 Form 4 Insider Report for VACCINEX, INC. (VCNX)
- Reporting relationship
- President and CEO, Director, 10%+ Owner
- Issuer ticker
- VCNX
- Reported as of
- 14 Nov 2024
- Net transaction value
- +$149,997
- SEC form
- 4
- Accepted by SEC
- 18 Nov 2024, 16:05:50 UTC
- Prior SEC filing
- 20 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Maurice Zauderer
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Maurice Zauderer filed Form 4 for VACCINEX, INC. (VCNX) on 18 Nov 2024.
Change
- Previous filing in this sequence was filed on 20 Sep 2024.
- Current net transaction value: +$149,997.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VCNX
transaction
Common Stock
Award
- Transaction value
- $149,997
- Shares
- +46,153
- Change %
- +18%
- Price
- $3.25
- Shares after
- 297,941
- Date
- 14 Nov 2024
- Ownership
- By Vaccinex (Rochester), L.L.C.
- Footnotes
- F2
VCNX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,580
- Date
- 14 Nov 2024
- Ownership
- Direct
VCNX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,016
- Date
- 14 Nov 2024
- Ownership
- By Jeremy C. Zauderer Trust
- Footnotes
- F1
VCNX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,011
- Date
- 14 Nov 2024
- Ownership
- By Jordan M. Zauderer Trust
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VCNX
holding
Derivative
Warrant (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 170,475
- Date
- 14 Nov 2024
- Ownership
- By Vaccinex (Rochester), L.L.C.
- Underlying class
- Common Stock
- Underlying amount
- 170,475
- Exercise price
- $5.64
- Footnotes
- F2
VCNX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 15
- Date
- 14 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15
- Exercise price
- $1491.00
- Footnotes
- F3
VCNX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 135
- Date
- 14 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 135
- Exercise price
- $1402.80
- Footnotes
- F3
VCNX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 66
- Date
- 14 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 66
- Exercise price
- $615.30
- Footnotes
- F4
VCNX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 133
- Date
- 14 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 133
- Exercise price
- $270.90
- Footnotes
- F5
VCNX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 266
- Date
- 14 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 266
- Exercise price
- $92.26
- Footnotes
- F6
VCNX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,877
- Date
- 14 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,877
- Exercise price
- $8.21
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Dr. Zauderer exercises voting control over shares held by this trust and disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.
Footnote F2
Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Footnote F3
Exercisable in full as of the date of this report.
Footnote F4
This option vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date, except as otherwise provided in the award notice.
Footnote F5
This option vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date, except as otherwise provided in the award notice.
Footnote F6
This option vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date, except as otherwise provided in the award notice.
Footnote F7
This option vests one-fourth on each of the first four anniversaries of the March 21, 2024 grant date, except as otherwise provided in the award notice.